Biomarkers of Mild and Moderate Traumatic Brain Injury

Completed

Conditions studied: Brain Injuries, Traumatic

In brief

The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI. The assay will be evaluated in a sample population of subjects over the age of 18 who have been referred to the health care provider for closed head injury evaluation.

Key facts

Study ID
NCT01295346
Run by
Banyan Biomarkers, Inc
People needed
290
Starts
2011-01-01
Expected to finish
2012-03-01
Last updated by the study team
2017-08-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.